Paper6138375
Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.
Packer M. J Am Coll Cardiol, 1983. Cited by 148 papers, by iCite.
Cite this record
ConductScience Library. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. Papers, record 6138375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6138375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiotonic Agents | Major topic |
| Heart Failure | Major topic |
| Vasodilator Agents | Major topic |
| Administration, Oral | |
| Calcium Channel Blockers | |
| Chronic Disease | |
| Drug Evaluation | |
| Drug Tolerance | |
| Humans | |
| Neurotransmitter Agents |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R23-HL-25055 | NHLBI NIH HHS | United States | R23HL025055 | PubMed and NIH |
Source NIH RePORTER
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25218145 | Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation. | Biochem Biophys Res Commun | 2014 | https://conductscience.org/library/papers/25218145 | PubMed |
| 6532481 | The role of digitalis in the future. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6532481 | PubMed |
| 3887015 | [Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure]. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/3887015 | PubMed |
| 3784463 | [Calcium antagonists in heart failure?]. | Klin Wochenschr | 1986 | https://conductscience.org/library/papers/3784463 | PubMed |
| 3758138 | The search of an ideal oral positive inotropic agent. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3758138 | PubMed |
| 3722083 | Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure. | Heart Vessels | 1986 | https://conductscience.org/library/papers/3722083 | PubMed |
| 3569109 | The future role of inotropic drugs. | Drugs | 1986 | https://conductscience.org/library/papers/3569109 | PubMed |
| 3552590 | The role of vasodilator therapy in the treatment of severe chronic heart failure. | Drugs | 1986 | https://conductscience.org/library/papers/3552590 | PubMed |
| 3281740 | Congestive heart failure. | CMAJ | 1988 | https://conductscience.org/library/papers/3281740 | PubMed |
| 3203040 | Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3203040 | PubMed |
| 3167315 | Proceedings of the British Pharmacological Society. Ireland, 6th-8th July, 1988. Abstracts. | Br J Pharmacol | 1988 | https://conductscience.org/library/papers/3167315 | PubMed |
| 3154305 | Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154305 | PubMed |
| 3120955 | Mortality in congestive heart failure: effects of vasodilator therapy. | Br Med J (Clin Res Ed) | 1987 | https://conductscience.org/library/papers/3120955 | PubMed |
| 2994697 | Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients. | Br Heart J | 1985 | https://conductscience.org/library/papers/2994697 | PubMed |
| 2656046 | Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2656046 | PubMed |
| 2653391 | Effect of flosequinan on exercise capacity and symptoms in severe heart failure. | Br Heart J | 1989 | https://conductscience.org/library/papers/2653391 | PubMed |
| 2598980 | Is addition of prazosin beneficial in chronic heart failure refractory to angiotensin converting enzyme inhibition? | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2598980 | PubMed |
| 2537095 | Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure. | Br Heart J | 1989 | https://conductscience.org/library/papers/2537095 | PubMed |
| 2487535 | Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2487535 | PubMed |
| 2487522 | New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2487522 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6138375
GET https://conductscience.org/api/papers/v1/6138375/cited_by?page=2